tirzepatide approved F.D.A. Approves New Obesity Drug That Will Compete With Wegovy Eli Lilly weight loss drug
Description
Since tirzepatide also slows gastric emptying, this effect can be compounded and worsen digestive upset
People with type 2 diabetes can now take Tirzepatide to help manage their blood sugar levels, by the Food and Drug Administration (FDA)
Do not use tirzepatide if you or a family member has a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Its a major win for the developers of tirzepatide (Mounjaro), Eli Lilly and Company, over those of semaglutide (Ozempic), Novo Nordisk
But individual variation is large, and some people remain sensitive to specific triggers throughout their treatment
